GSK-489C

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGSK-489C
Drug Alias Namesecond-generation ronacaleret analogs (GSK)GSK-489C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor antagonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A